Breaking News Instant updates and real-time market news.

PTGX

Protagonist Therapeutics

$11.10

4.08 (58.12%)

08:55
08/07/18
08/07
08:55
08/07/18
08:55

Protagonist to offer 2.75M shares, warrants via Securities Purchase Agreement

Protagonist Therapeutics announced in a regulatory filing that on August 6 it entered into a Securities Purchase Agreement with certain purchasers pursuant to which the company will offer to the purchasers, up to an aggregate of an aggregate of 2.75M shares of common stock at a negotiated purchase price of $8.00 per share, for aggregate gross proceeds to the company of approximately $22M, before deducting estimated offering expenses payable by the company. In a concurrent private placement, the company is selling warrants to purchase an aggregate of 2.75M shares of common stock. Each Warrant will be exercisable from the date of issuance of the common stock until the five-year anniversary of the closing date. Warrants to purchase 1.375M shares will have an exercise price of $10.00 per share and Warrants to purchase 1.375M shares will have an exercise price of $15.00 per share.

PTGX Protagonist Therapeutics
$11.10

4.08 (58.12%)

03/27/18
BMOC
03/27/18
NO CHANGE
Target $13
BMOC
Outperform
Protagonist Therapeutics price target lowered to $13 from $42 at BMO Capital
BMO Capital analyst M. Ian Somaiya slashed his price target on Protagonist Therapeutics (PTGX) to $13 following the announcement that the company is discontinuing its Phase 2b study of PTG-100 in patients with moderate to severe ulcerative colitis. Somaiya adds that his valuation is now driven by the risk-adjusted sales model for PTG-200, which "represents a higher probability clinical program with peak sales of over $2B". The analyst also notes that he continues to exclude the clinical data of PTG-300 from his model. Despite the steep price target revision, Somaiya keeps his Outperform rating and recommends that investors buy into the weakness after the PTG-100 clinical disappointment on anticipated PTG-200 data and the advancement of Johnson&Johnson (JNJ) - shared Stelara.
06/06/18
LEHM
06/06/18
DOWNGRADE
Target $8.5
LEHM
Equal Weight
Protagonist downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Douglas Tsao downgraded Protagonist Therapeutics to Equal Weight and lowered his price target for the shares to $8.50 from $30. The analyst continues to see value in the company's pipeline assets, but does expect achievement of key catalysts until the second half of 2019. As such, the analyst sees greater near-term potential in small cap names with catalysts upcoming, such as Foamix (FOMX).
08/06/18
LEER
08/06/18
NO CHANGE
Target $21
LEER
Outperform
Protagonist price target raised to $21 after study re-analysis at Leerink
Leerink analyst Joseph P. Schwartz raised his price target on Protagonist Therapeutics shares to $21 from $13 after the company announced results from an independent blinded re-analysis of the Phase 2 PROPEL study of oral alpha-4-beta-7 integrin antagonist PTG-100 for the treatment of patients with ulcerative colitis. He maintains an Outperform rating on Protagonist shares.
08/06/18
LEER
08/06/18
NO CHANGE
Target $21
LEER
Outperform
Protagonist Therapeutics' PTG-100 'back on track,' says Leerink
Leerink analyst Joseph Schwartz says PTG-100 in Ulcerative colitis is "back on track," increasing his confidence in Protagonist Therapeutics' peptide technology platform. The analyst notes that the company reported this morning an unexpected, but very positive, turnaround of its lead program, PTG-100, and will now pursue late-stage clinical development, assuming a positive discussion with the FDA occurs in 2H. While it is unfortunate that the program lost some time when the data set was initially mis-scored and deemed futile when in fact today's news suggests that PTG-100 could have robust clinical efficacy, Schwartz believes that Protagonist's persistence to uncover the truth leading to the resuscitation of the program is positive. The analyst reiterates an Outperform rating on the stock and raised his price target on the shares to $21 from $13.

TODAY'S FREE FLY STORIES

ENS

EnerSys

$66.07

0.2997 (0.46%)

12:07
06/24/19
06/24
12:07
06/24/19
12:07
Conference/Events
EnerSys management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

GBT

Global Blood Therapeutics

$64.21

1.2 (1.90%)

12:05
06/24/19
06/24
12:05
06/24/19
12:05
Options
Global Blood Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$37.20

7.92 (27.05%)

12:03
06/24/19
06/24
12:03
06/24/19
12:03
Recommendations
Krystal Biotech analyst commentary  »

Krystal Biotech price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

CNC

Centene

$55.52

-0.86 (-1.53%)

, WCG

WellCare

$296.08

-3.1 (-1.04%)

12:01
06/24/19
06/24
12:01
06/24/19
12:01
Hot Stocks
Centene, WellCare stockholders approve proposals regarding WellCare acquisition »

Centene Corporation (CNC)…

CNC

Centene

$55.52

-0.86 (-1.53%)

WCG

WellCare

$296.08

-3.1 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

QUAD

Quad/Graphics

$8.16

-0.94 (-10.33%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
Quad/Graphics falls -10.5% »

Quad/Graphics is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBH

Sally Beauty

$13.02

-1.77 (-11.97%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
Sally Beauty falls -11.9% »

Sally Beauty is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$171.00

-25.38 (-12.92%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN falls -13.0% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTEC

Rudolph Technologies

$27.82

2.81 (11.24%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
Rudolph Technologies rises 11.0% »

Rudolph Technologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 10

    Jul

TLRD

Tailored Brands

$6.16

0.62 (11.19%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
Tailored Brands rises 11.0% »

Tailored Brands is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$15.45

1.71 (12.45%)

12:00
06/24/19
06/24
12:00
06/24/19
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN rises 12.6% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
06/24/19
06/24
11:55
06/24/19
11:55
General news
Treasury's $72 B 3- and 6-month bill auctions were ok but sloppy »

Treasury's $72 B 3-…

INGN

Inogen

$72.22

0.93 (1.30%)

11:55
06/24/19
06/24
11:55
06/24/19
11:55
Conference/Events
William Blair medical tech analyst to hold a luncheon »

Medical Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 26

    Aug

GTLS

Chart Industries

$70.49

0.33 (0.47%)

11:54
06/24/19
06/24
11:54
06/24/19
11:54
Conference/Events
Chart Industries management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Jul

SPY

SPDR S&P 500 ETF Trust

$294.30

0.31 (0.11%)

, SPX

S&P 500

$0.00

(0.00%)

11:50
06/24/19
06/24
11:50
06/24/19
11:50
General news
Trump signing executive order for 'strong sanctions' on Iran, Bloomberg reports »

Bloomberg quotes…

SPY

SPDR S&P 500 ETF Trust

$294.30

0.31 (0.11%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$22.55

-0.28 (-1.23%)

11:50
06/24/19
06/24
11:50
06/24/19
11:50
Options
Halliburton trader exits late-may risk-reversal for a loss »

Halliburton trader exits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 27

    Aug

  • 13

    Nov

KRYS

Krystal Biotech

$37.20

7.92 (27.05%)

11:46
06/24/19
06/24
11:46
06/24/19
11:46
Recommendations
Krystal Biotech analyst commentary  »

Krystal Biotech price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

TLRD

Tailored Brands

$6.11

0.565 (10.20%)

11:45
06/24/19
06/24
11:45
06/24/19
11:45
Options
Tailored Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$149.94

1.77 (1.19%)

, AAPL

Apple

$199.39

0.62 (0.31%)

11:44
06/24/19
06/24
11:44
06/24/19
11:44
Periodicals
Apple hits back at Spotify's claims of unfair App Store treatment, AI reports »

Apple (AAPL) is hitting…

SPOT

Spotify

$149.94

1.77 (1.19%)

AAPL

Apple

$199.39

0.62 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

11:43
06/24/19
06/24
11:43
06/24/19
11:43
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:43
06/24/19
06/24
11:43
06/24/19
11:43
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

OXFD

Oxford Immunotec

$13.88

-0.22 (-1.56%)

11:37
06/24/19
06/24
11:37
06/24/19
11:37
Hot Stocks
Oxford Immunotec appoints Patrick Balthrop, Sr. as Chairman »

Oxford Immunotec…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$149.99

1.82 (1.23%)

, DE

Deere

$167.23

2.94 (1.79%)

11:33
06/24/19
06/24
11:33
06/24/19
11:33
On The Fly
Spotify downgrade, Deere upgrade among today's top analyst calls »

Check out today's top…

SPOT

Spotify

$149.99

1.82 (1.23%)

DE

Deere

$167.23

2.94 (1.79%)

AGCO

Agco

$76.63

1.92 (2.57%)

IP

International Paper

$42.49

-1.13 (-2.59%)

OXY

Occidental Petroleum

$49.84

-0.78 (-1.54%)

APC

Anadarko

$70.20

-0.17 (-0.24%)

OAS

Oasis Petroleum

$5.45

-0.27 (-4.72%)

SHOP

Shopify

$315.91

-10.77 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

  • 10

    Jul

  • 17

    Jul

  • 27

    Aug

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

FB

Facebook

$193.42

2.26 (1.18%)

11:30
06/24/19
06/24
11:30
06/24/19
11:30
Options
Lots of likes for short-term Facebook upside calls »

Lots of likes for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 16

    Jul

SIG

Signet Jewelers

$17.49

-0.13 (-0.74%)

11:25
06/24/19
06/24
11:25
06/24/19
11:25
Options
Signet Jewelers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVTY

Tivity Health

$17.18

-0.23 (-1.32%)

11:24
06/24/19
06/24
11:24
06/24/19
11:24
Conference/Events
Tivity Health management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 14

    Aug

  • 15

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.